Synthesis and anti-leishmanial activities of uniflorol analogues

IF 2.6 4区 医学 Q3 CHEMISTRY, MEDICINAL
Paula da Silva Cardoso, Luana Budny Niero, Tiago Elias Allievi Frizon, Silvia DalBó, Anne Cécile Le Lamer, Nicolas Gouault, Patrícia de Aguiar Amaral, James W. Barlow
{"title":"Synthesis and anti-leishmanial activities of uniflorol analogues","authors":"Paula da Silva Cardoso,&nbsp;Luana Budny Niero,&nbsp;Tiago Elias Allievi Frizon,&nbsp;Silvia DalBó,&nbsp;Anne Cécile Le Lamer,&nbsp;Nicolas Gouault,&nbsp;Patrícia de Aguiar Amaral,&nbsp;James W. Barlow","doi":"10.1007/s00044-024-03275-3","DOIUrl":null,"url":null,"abstract":"<div><p>Chromanones are a subset of the benzopyran family, and display diverse biological activities, both as natural products and synthetic derivatives. Among these, we selected the natural product uniflorol, a 4-chromanone with an α,β-unsaturated ketone side chain, as a lead compound due to its reported anti-leishmanial properties. We designed and synthesised four series of novel compounds, varying the substitution patterns around the benzopyran core, and evaluated the compounds for anti-leishmanial activity against amastigotes of <i>L. infantum</i>. We prepared and characterised 24 novel compounds; upon screening, 12 compounds demonstrated activity values of &lt;50 μM, with the most potent compound, <b>16d</b>, having an IC<sub>50</sub> of 7.29 μM. Activity was favoured in compounds bearing a phenylalkenyl motif, such as cinnamyl, styryl or a more lipophilic extension, and amide analogues retained activity. Uniflorol analogues display promise as novel architectures towards the development of potential anti-leishmanial agents.</p><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":699,"journal":{"name":"Medicinal Chemistry Research","volume":"33 9","pages":"1657 - 1670"},"PeriodicalIF":2.6000,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00044-024-03275-3.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00044-024-03275-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Chromanones are a subset of the benzopyran family, and display diverse biological activities, both as natural products and synthetic derivatives. Among these, we selected the natural product uniflorol, a 4-chromanone with an α,β-unsaturated ketone side chain, as a lead compound due to its reported anti-leishmanial properties. We designed and synthesised four series of novel compounds, varying the substitution patterns around the benzopyran core, and evaluated the compounds for anti-leishmanial activity against amastigotes of L. infantum. We prepared and characterised 24 novel compounds; upon screening, 12 compounds demonstrated activity values of <50 μM, with the most potent compound, 16d, having an IC50 of 7.29 μM. Activity was favoured in compounds bearing a phenylalkenyl motif, such as cinnamyl, styryl or a more lipophilic extension, and amide analogues retained activity. Uniflorol analogues display promise as novel architectures towards the development of potential anti-leishmanial agents.

Abstract Image

单叶酚类似物的合成和抗利什曼病活性
色满酮是苯并吡喃家族的一个分支,作为天然产物和合成衍生物具有多种生物活性。其中,我们选择了天然产物 uniflorol 作为先导化合物,它是一种具有 α、β-不饱和酮侧链的 4-色满酮,据报道具有抗利什曼病的特性。我们设计并合成了四个系列的新型化合物,改变了苯并吡喃核心周围的取代模式,并评估了这些化合物对婴儿淋巴细胞无丝分裂体的抗利什曼病活性。我们制备了 24 个新型化合物并对其进行了表征;经过筛选,12 个化合物的活性值达到 50 μM,其中最有效的化合物 16d 的 IC50 值为 7.29 μM。具有苯基烯基(如肉桂基、苯乙烯基或更亲脂的延伸部分)的化合物更具有活性,而酰胺类似物则保持了活性。Uniflorol 类似物有望成为开发潜在抗利什曼病原体制剂的新型结构。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicinal Chemistry Research
Medicinal Chemistry Research 医学-医药化学
CiteScore
4.70
自引率
3.80%
发文量
162
审稿时长
5.0 months
期刊介绍: Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of molecular biology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信